Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.97 USD | -4.57% |
|
-4.57% | +0.25% |
Sales 2024 * | 346M 253M 19.99B | Sales 2025 * | 356M 260M 20.59B | Capitalization | 555M 406M 32.08B |
---|---|---|---|---|---|
Net income 2024 * | 2M 1.46M 116M | Net income 2025 * | 13M 9.5M 751M | EV / Sales 2024 * | 1.6 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 1.56 x |
P/E ratio 2024 * |
192
x | P/E ratio 2025 * |
53.7
x | Employees | 725 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.52% |
Latest transcript on Knight Therapeutics Inc.
1 day | -4.57% | ||
1 week | -4.57% | ||
Current month | -9.17% | ||
1 month | -9.77% | ||
3 months | -1.20% | ||
6 months | +1.72% | ||
Current year | +0.25% |
![Extreme 3.96](/images/extremecours_fleche.png)
![Extreme 3.96](/images/extremecours_fleche.png)
![Extreme 3.855](/images/extremecours_fleche.png)
![Extreme 3.201](/images/extremecours_fleche.png)
![Extreme 3.19](/images/extremecours_fleche.png)
![Extreme 3.19](/images/extremecours_fleche.png)
![Extreme 3.19](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Samira Sakhia
CEO | Chief Executive Officer | 55 | 31/10/13 |
Jonathan Goodman
FOU | Founder | 56 | 31/10/13 |
Arvind Utchanah
DFI | Director of Finance/CFO | - | 19/06/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Gale
BRD | Director/Board Member | 74 | 05/01/14 |
Jonathan Goodman
FOU | Founder | 56 | 31/10/13 |
Robert Lande
BRD | Director/Board Member | 61 | 31/12/12 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.98% | 9.14B | |
-23.31% | 4.33B | |
+15.70% | 4.28B | |
+32.83% | 4.15B | |
+10.63% | 2.19B | |
+9.30% | 1.98B | |
-33.37% | 1.98B | |
-0.50% | 1.64B | |
-46.20% | 1.68B |
- Stock Market
- Equities
- GUD Stock
- KHTRF Stock